About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
HISTORICAL VOLUME
Historical
Volume
Glaxosmithkline Pharmaceuticals Ltd.
BSE Code
500660
ISIN Demat
INE159A01016
Book Value
98.85
NSE Code
GLAXO
Dividend Yield %
1.40
Market Cap
387008.08
P/E
57.86
EPS
39.49
Face Value
10
Exchange :
BSE
NSE
Period From :
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
DEC
2024
2023
Period To :
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
DEC
2024
2023
Date
Open Price(Rs.)
High Price(Rs.)
Low Price(Rs.)
Close Price(Rs.)
Volume
Turnover
20-Dec-2024
2342.85
2342.85
2266.70
2284.50
2104
4841776
19-Dec-2024
2300.00
2336.35
2285.35
2325.25
3135
7227741
18-Dec-2024
2319.95
2340.20
2271.65
2334.95
3765
8728865
17-Dec-2024
2289.95
2293.10
2253.45
2264.65
4872
11055216
16-Dec-2024
2262.40
2285.25
2229.00
2278.95
8335
18747178
13-Dec-2024
2310.00
2310.00
2250.85
2254.45
3421
7753096
12-Dec-2024
2345.50
2345.50
2296.65
2306.65
2393
5526002
11-Dec-2024
2354.90
2375.20
2326.05
2345.45
2635
6194502
10-Dec-2024
2340.00
2346.15
2320.00
2328.95
3398
7927348
09-Dec-2024
2343.00
2363.15
2323.10
2328.20
2327
5431935
06-Dec-2024
2437.95
2437.95
2335.00
2346.40
1939
4570668
05-Dec-2024
2401.70
2407.75
2361.10
2377.10
1154
2740024
04-Dec-2024
2453.95
2453.95
2380.00
2401.70
1425
3433331
03-Dec-2024
2409.25
2459.95
2408.45
2422.10
3097
7517092
02-Dec-2024
2440.00
2451.40
2392.70
2409.25
3705
8943556
Page
1
of
1
Prev
||
Next
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.